MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 226 filers reported holding MYRIAD GENETICS INC in Q4 2016. The put-call ratio across all filers is 9.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $74,000 | +15.6% | 3,849 | 0.0% | 0.06% | +11.8% |
| Q4 2016 | $64,000 | -19.0% | 3,849 | 0.0% | 0.05% | -20.3% |
| Q3 2016 | $79,000 | -33.1% | 3,849 | 0.0% | 0.06% | -34.0% |
| Q2 2016 | $118,000 | -23.9% | 3,849 | -7.2% | 0.10% | -27.6% |
| Q1 2016 | $155,000 | -13.4% | 4,149 | 0.0% | 0.13% | -15.2% |
| Q4 2015 | $179,000 | +7.2% | 4,149 | -6.7% | 0.16% | +0.6% |
| Q3 2015 | $167,000 | +10.6% | 4,449 | 0.0% | 0.16% | +23.6% |
| Q2 2015 | $151,000 | -3.8% | 4,449 | 0.0% | 0.13% | -5.2% |
| Q1 2015 | $157,000 | -7.1% | 4,449 | -10.1% | 0.13% | -8.2% |
| Q4 2014 | $169,000 | – | 4,949 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |